Back to Search
LEILA KUTTEH, M.D.
M.D.
Medical Oncology Physician
NPI: 1679558340Individual
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
32832(IA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
32832(IA)
Research & Publications (8)
Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831.
PMID 19349549·J Clin Oncol·2009
3-trial
The effect of tamoxifen or exemestane on bone mineral density during the first 2 years of adjuvant treatment of postmenopausal women with early breast cancer.
PMID 19073509·Clin Breast Cancer·2008
4-observational
Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3).
PMID 17853395·Cancer·2007
3-trial
Topotecan and paclitaxel in previously treated patients with relapsed small cell lung cancer: phase II trial of the North Central Cancer Treatment Group.
PMID 17409859·J Thorac Oncol·2006
3-trial
Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial.
PMID 16770976·Mayo Clin Proc·2006
3-trial
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
PMID 16236738·N Engl J Med·2005
3-trial
Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients.
PMID 14505160·Support Care Cancer·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 701 10TH ST SE, HPCC 3RD FLOOR
CEDAR RAPIDS, IA 52403 - Phone
- (319) 363-8303
Quick Facts
- NPI
- 1679558340
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile